Ontario Superior Court summarily dismisses Apotex’s novel monetary claims under Statutes of Monopolies, Trademarks Act, and at common law
Pharma in Brief
MARCH 18, 2021
On March 8, 2021, the Ontario Superior Court granted summary judgment dismissing novel claims by Apotex under the UK and Ontario Statutes of Monopolies , the Trademarks Act , and at common law. Apotex Inc. and Apotex Pharmachem Inc. As such, Apotex was unable to obtain its Notice of Compliance ( NOC ) for olanzapine.
52 
Let's personalize your content